Biotech Analysis Central

• 10/20/2024

  Elevance Health’s Q3 Struggles: Industry Headwinds Take a Toll

• 10/20/2024

  TSMC: The Nanometer Shrinker Driving Revenue Growth

• 10/19/2024

  Wave Life Sciences: AATD Breakthrough Sets Stage for 2025 Catalyst

• 10/19/2024

  UnitedHealth Q3 Earnings: Why the Sell-Off Isn’t a Buying Opportunity

• 10/17/2024

  Silicon Labs’ Mixed Bag: Improving Results Marred by Uncertain Future

• 10/9/2024

  **2 Stocks with Massive Upside Potential: 32% and 282% Gains Forecasted**

• 10/8/2024

  **NovoCure’s Stock Flatlines Amid Limited Progress**

• 10/8/2024

  **Cathie Wood’s Latest Buys: 3 Stocks on Sale**

• 10/8/2024

  **EGFRm NSCLC Targeting: Q1 2025 Data Update**

• 10/7/2024

  **Scholar Rock Advances SMA Program with Positive Clinical Results**